The therapeutic potential of CD39: interview with Dr Simon Robson

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.10, Iss.5, 2006-10, pp. : 649-652

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Therapeutic Potential of 4-1BB (CD137) in Cancer

Current Cancer Drug Targets, Vol. 5, Iss. 5, 2005-08 ,pp. : 357-363

Bentham Science Publishers

Access to resources Recommend Favorite

Thromboregulatory potential of endothelial CD39/nucleoside triphosphate diphosphohydrolase: modulation of purinergic signalling in platelets

By Robson S.C. Sévigny J. Imai M. Guckelberger O. Enjyoji K.

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 2, 2000-04 ,pp. : 155-171

Informa Healthcare

Access to resources Recommend Favorite

New Developments in Anti-Platelet Therapies Potential Use of CD39/Vascular ATP Diphosphohydrolase in Thrombotic Disorders

Current Drug Targets, Vol. 1, Iss. 3, 2000-11 ,pp. : 285-296

Bentham Science Publishers

Access to resources Recommend Favorite

CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer

Current Cancer Drug Targets, Vol. 10, Iss. 3, 2010-05 ,pp. : 287-306

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of the

By Levy Ofer

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 2, 2002-02 ,pp. : 159-167

Informa Healthcare

Access to resources Recommend Favorite